Lv11
30 积分 2025-04-12 加入
Tislelizumab plus chemotherapy as first-line treatment for recurrent or metastatic nasopharyngeal cancer: A multicenter phase 3 trial (RATIONALE-309)
53分钟前
待确认
Final Overall Survival Analysis of Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma: A Multicenter, Randomized Phase III Trial
2小时前
已完结
乳腺癌术后放疗靶区勾画和计划设计指南
18天前
已完结
Impact of an Epstein-Barr Virus Serology-Based Screening Program on Nasopharyngeal Carcinoma Mortality: A Cluster-Randomized Controlled Trial
21天前
已完结
皖公网安备34019202002308
